Thanks to advancements of cancer treatments, the cancer death rate has decreased 23% from 1999 to 2019 in the United States. Nevertheless, lung cancer remains the leading cause of cancer death in 2022 in the United States. In patients with non-small cell lung cancer (NSCLC), the 5-year survival ...
Non-small cell lung cancer (NSCLC) is the third most common type of cancer in the Unites States (US). It is known to harbor many types of mutations, making it particularly difficult to define the best treatment algorithm for a patient, especially after first line treatment. Over the last few ...
-1.jpg?width=40&name=Untitled%20design%20(1)-1.jpg){kind=avatar}
Tori Gray, PharmD Candidate & Megan B May, PharmD, BCOP